Literature DB >> 16365557

The role of eyewall resection in uveal melanoma management.

Bertil Damato1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16365557     DOI： 10.1097/01.iio.0000195862.71558.c8

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN： 0020-8167


× No keyword cloud information.
  7 in total

Review 1.  Uveal melanoma: relatively rare but deadly cancer.

Authors:  S Kaliki; C L Shields
Journal:  Eye (Lond)       Date:  2016-12-02       Impact factor: 3.775

2.  Initial results of fractionated CyberKnife radiosurgery for uveal melanoma.

Authors:  Faruk Zorlu; Ugur Selek; Hayyam Kiratli
Journal:  J Neurooncol       Date:  2009-02-22       Impact factor: 4.130

Review 3.  Choroidal Melanoma Resection.

Authors:  Hany S Hamza; Abdelrahman M Elhusseiny
Journal:  Middle East Afr J Ophthalmol       Date:  2018 Apr-Jun

4.  Surgical Resection of Intraocular Tumors (Partial Transscleral Sclerouvectomy Combined With Mircoinvasive Vitrectomy and Reconstruction of the Eyeball) in Asian Patients: Twenty-Five Years Results.

Authors:  Nan Zhou; Ping Wang; Xiaolin Xu; Yueming Liu; Wenbin Wei
Journal:  Front Oncol       Date:  2022-03-15       Impact factor: 6.244

Review 5.  Future perspectives of uveal melanoma blood based biomarkers.

Authors:  Aaron B Beasley; Fred K Chen; Timothy W Isaacs; Elin S Gray
Journal:  Br J Cancer       Date:  2022-02-21       Impact factor: 9.075

6.  Commentary: Vitrectomy as a treatment modality in vitreous seeding secondary to ciliary body melanocytoma.

Authors:  Pukhraj Rishi
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

7.  Clinical Outcomes after Surgical Resection Combined with Brachytherapy for Uveal Melanomas.

Authors:  Isabel Relimpio-López; Antonio Manuel Garrido-Hermosilla; Francisco Espejo; María Gessa-Sorroche; Lourdes Coca; Belen Domínguez; María Jesús Díaz-Granda; Beatriz Ponte; María José Cano; Enrique Rodríguez de la Rúa; Francisco Carrasco-Peña; Carlos Míguez; Jonathan Saavedra; Antonio Ontanilla; Carlos Caparrós-Escudero; Juan José Ríos; José Antonio Terrón
Journal:  J Clin Med       Date:  2022-03-15       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.